These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 27334231

  • 1. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
    Kim M, Kim J, Lee JH, Hwang YM, Kim MS, Nam GB, Choi KJ, Kim JJ, Kim YH.
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM, Sobrino-Márquez JM, Grande-Trillo A, Lage-Gallé E, Rangel-Sousa D, Esteve-Ruiz IM, Martínez-Martínez A.
    Transplant Proc; 2013 Oct; 45(10):3659-61. PubMed ID: 24314988
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
    Galve E, Oristrell G, Acosta G, Ribera-Solé A, Moya-Mitjans À, Ferreira-González I, Pérez-Rodon J, García-Dorado D.
    Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094
    [Abstract] [Full Text] [Related]

  • 8. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
    Paiman EHM, Androulakis AFA, Shahzad R, Tao Q, Zeppenfeld K, Lamb HJ, van der Geest RJ.
    J Cardiovasc Magn Reson; 2019 May 16; 21(1):28. PubMed ID: 31096987
    [Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD.
    Clin J Am Soc Nephrol; 2015 Jul 07; 10(7):1119-27. PubMed ID: 26111859
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease.
    Nishikawa T, Fujino M, Nakajima I, Asaumi Y, Kataoka Y, Anzai T, Kusano K, Noguchi T, Goto Y, Nishimura K, Miyamoto Y, Kiso K, Yasuda S.
    Europace; 2017 Jul 01; 19(7):1153-1162. PubMed ID: 27738062
    [Abstract] [Full Text] [Related]

  • 14. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P, Accogli M, Pisanò EC, Zaccaria M, De Blasi S, Ponzetta MA, Valsecchi S, Milanese G, Lauretti M, Magliari F.
    Europace; 2016 Sep 01; 18(9):1374-82. PubMed ID: 26612878
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chagas disease is associated with a worse prognosis at 1-year follow-up after implantable cardioverter-defibrillator for secondary prevention in heart failure patients.
    Vieira de Melo RM, de Azevedo DFC, Lira YM, Cardoso de Oliveira NF, Passos LCS.
    J Cardiovasc Electrophysiol; 2019 Nov 01; 30(11):2448-2452. PubMed ID: 31502385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L, Pasceri V, Mollica C, Ficili S, Poti G, Aquilani S, Santini M, La Rocca S.
    J Cardiovasc Med (Hagerstown); 2011 May 01; 12(5):334-9. PubMed ID: 21487343
    [Abstract] [Full Text] [Related]

  • 19. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, McNitt S, Jons C, Moss AJ, Zareba W.
    Circulation; 2014 Dec 23; 130(25):2278-86. PubMed ID: 25301831
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.